Solventum (SOLV) Competitors $65.72 -0.40 (-0.61%) Closing price 05/1/2025 03:59 PM EasternExtended Trading$65.64 -0.07 (-0.11%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SOLV vs. GEHC, PHG, ZBH, SNN, PEN, STVN, GKOS, BLCO, INSP, and NARIShould you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), and Inari Medical (NARI). These companies are all part of the "medical equipment" industry. Solventum vs. GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Smith & Nephew Penumbra Stevanato Group Glaukos Bausch + Lomb Inspire Medical Systems Inari Medical Solventum (NYSE:SOLV) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, community ranking, media sentiment, institutional ownership, earnings, profitability, valuation and risk. Does the MarketBeat Community believe in SOLV or GEHC? GE HealthCare Technologies received 30 more outperform votes than Solventum when rated by MarketBeat users. Likewise, 64.58% of users gave GE HealthCare Technologies an outperform vote while only 4.00% of users gave Solventum an outperform vote. CompanyUnderperformOutperformSolventumOutperform Votes14.00%Underperform Votes2496.00% GE HealthCare TechnologiesOutperform Votes3164.58% Underperform Votes1735.42% Does the media refer more to SOLV or GEHC? In the previous week, GE HealthCare Technologies had 27 more articles in the media than Solventum. MarketBeat recorded 43 mentions for GE HealthCare Technologies and 16 mentions for Solventum. Solventum's average media sentiment score of 1.10 beat GE HealthCare Technologies' score of 0.88 indicating that Solventum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 11 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GE HealthCare Technologies 20 Very Positive mention(s) 1 Positive mention(s) 10 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Positive Do insiders and institutionals have more ownership in SOLV or GEHC? 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.1% of Solventum shares are held by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has stronger valuation & earnings, SOLV or GEHC? GE HealthCare Technologies has higher revenue and earnings than Solventum. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventum$8.25B1.38$475.76M$2.7523.90GE HealthCare Technologies$19.67B1.57$1.99B$4.3315.63 Do analysts prefer SOLV or GEHC? Solventum currently has a consensus target price of $79.29, indicating a potential upside of 20.65%. GE HealthCare Technologies has a consensus target price of $89.40, indicating a potential upside of 32.11%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts clearly believe GE HealthCare Technologies is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00GE HealthCare Technologies 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.82 Is SOLV or GEHC more profitable? GE HealthCare Technologies has a net margin of 10.13% compared to Solventum's net margin of 0.00%. GE HealthCare Technologies' return on equity of 25.74% beat Solventum's return on equity.Company Net Margins Return on Equity Return on Assets SolventumN/A N/A N/A GE HealthCare Technologies 10.13%25.74%6.29% SummaryGE HealthCare Technologies beats Solventum on 16 of the 18 factors compared between the two stocks. Get Solventum News Delivered to You Automatically Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SOLV vs. The Competition Export to ExcelMetricSolventumSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$11.37B$4.33B$5.47B$18.90BDividend YieldN/A39.93%5.11%4.01%P/E Ratio23.9030.0322.5132.87Price / Sales1.3855.31397.6227.89Price / CashN/A51.0838.1817.52Price / BookN/A6.056.734.47Net Income$475.76M$68.71M$3.22B$1.02B7 Day Performance-2.67%0.05%1.58%0.73%1 Month Performance-13.85%-2.15%4.05%-2.62%1 Year Performance0.87%22.61%15.75%4.59% Solventum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SOLVSolventum1.4937 of 5 stars$65.72-0.6%$79.29+20.6%+0.9%$11.37B$8.25B23.9022,000Upcoming EarningsAnalyst ForecastPositive NewsGEHCGE HealthCare Technologies4.4739 of 5 stars$68.07-0.5%$96.50+41.8%-13.5%$31.17B$19.67B15.7250,000Earnings ReportAnalyst ForecastBuyback AnnouncementPHGKoninklijke Philips2.9826 of 5 stars$25.26+0.9%N/A-6.6%$23.74B$18.02B-30.0778,200Upcoming EarningsShort Interest ↑ZBHZimmer Biomet4.7377 of 5 stars$101.85+0.3%$124.15+21.9%-14.8%$20.15B$7.68B22.8918,000Upcoming EarningsPositive NewsSNNSmith & Nephew1.9928 of 5 stars$26.76+0.5%$27.00+0.9%+17.1%$11.72B$5.81B12.3920,100Analyst ForecastPENPenumbra4.1706 of 5 stars$297.51-0.8%$302.40+1.6%+42.0%$11.52B$1.24B875.033,900Insider TradeSTVNStevanato Group1.1525 of 5 stars€21.51-0.4%N/A-26.5%$6.51B$1.10B45.774,650Positive NewsGKOSGlaukos4.8029 of 5 stars$93.68-3.1%$156.17+66.7%-15.8%$5.35B$383.48M-32.64780Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap DownBLCOBausch + Lomb3.702 of 5 stars$13.65-0.6%$18.82+37.9%-15.6%$4.82B$4.79B-15.0012,500Earnings ReportAnalyst ForecastINSPInspire Medical Systems4.8554 of 5 stars$157.79-0.8%$218.90+38.7%-35.2%$4.70B$802.80M91.21760Upcoming EarningsNARIInari MedicalN/A$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800 Related Companies and Tools Related Companies GEHC Alternatives PHG Alternatives ZBH Alternatives SNN Alternatives PEN Alternatives STVN Alternatives GKOS Alternatives BLCO Alternatives INSP Alternatives NARI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SOLV) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SOLV Stock Free SOLV Stock Alerts